GlaxoSmithKline (GSK) announces Shingrix approved in US for prevention of shingles in immunocompromised adults
Go back to GlaxoSmithKline (GSK) announces Shingrix approved in US for prevention of shingles in immunocompromised adults| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 40.91 +0.05 (0.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.86 | 52 Week High | $45.58 | |||
| Open | $41.06 | 52 Week Low | $37.82 | |||
| Day High | $41.11 | P/E | N/A | |||
| Day Low | $40.81 | EPS | $0.00 | |||
| Volume | 3,461,977 | |||||
